Get the app
US › Healthcare

BrightSpring Health Services, Inc. Common Stock (BTSG)

US · Healthcare · Health Information Services

$67.15+1.96%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue
$4.21B
Revenue YoY
+26.4%
Net profit
$100.1M
Profit YoY
+79.3%
EPS
$0.54
EPS estimate
$0.45
Net margin
2.4%

EPS came in at 0.54 against a street estimate of 0.45 — a beat of 20.0%.

Key statistics

Market cap
$13.31B
P/E
59.2
Forward P/E
23.1
P/B
6.12
Book value
$9.94
EPS (TTM)
$1.13
52-week high
$73.75
52-week low
$30.64
50-day MA
$59.94
200-day MA
$54.68
Beta
1.88

Analyst view

Analysts rate BrightSpring Health Services, Inc. Common Stock a strong buy (18 buy, 0 hold, 0 sell out of 18) with an average price target of $81.59.

From the latest earnings call · 2026-10-30

CONFIDENT BrightSpring delivered strong Q3 growth, raised 2026 EBITDA guidance, and expects 15%-20% organic EBITDA growth in 2027, supported by specialty pharmacy, provider services and M&A. Q3 FY26 The call did not discuss geographic regional performance. Analysts focused on specialty-pharmacy growth, LDD economics, M&A, infusion capacity, Home and Community Pharmacy recovery, ACOs, cash flow and AI. Management emphasized durable demand, operational execution, pipeline strength and disciplined investment, while declining to discuss individual drugs or detailed 2027 figures. 2026-10-30…

Full summary in the app.

Shareholding

Insiders
3.10%
Institutions
107.92%

Largest institutional holders

FundStake
Kohlberg Kravis Roberts & Co LP13.56%
BlackRock Inc12.14%
FMR Inc6.77%
Amvescap Plc.6.04%
Vanguard Portfolio Management, LLC5.03%
T. Rowe Price Associates, Inc.5.00%
Vanguard Capital Management, LLC3.70%
State Street Corp3.17%

Recent filings & reports

DocumentDate
Quarterly report · Q3 2026
HEADLINE NUMBERS • Third-quarter 2026 revenue was $4,213,234 thousand, up from $3,334,106 thousand in the third quarter of 2025. • Nine-month 2026 r
2026-10-30
Results announced · Q4 2026
HEADLINE NUMBERS • Third-quarter 2026 revenue was $4,213 million, up 26.4% from $3,334 million in Q3 2025. • Gross profit was $519 million, up 32.3%
2026-10-30
Quarterly report · Q2 2026
BRIGHTSPRING HEALTH SERVICES, INC. - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues: $3.87 billion (Q2 2026), up 23% vs Q2 2025 ($3.15 billi
2026-07-31
Results announced · Q3 2026
BRIGHTSPRING HEALTH SERVICES, INC. – Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Net revenue Q2 2026: $3,873 million, up 23.0% vs. $3,148 million Q2
2026-07-31
Board / officer change · Q2 2026
BRIGHTSPRING HEALTH SERVICES, INC. – 8-K SUMMARY HEADLINE NUMBERS • Board Size: Expanded from 7 to 8 directors on June 11, 2026 • New Director: Dr.
2026-06-12
Material agreement · Q2 2026
BRIGHTSPRING HEALTH SERVICES, INC. - 8-K SUMMARY HEADLINE NUMBERS • Stock offering price: $58.75 per share • Shares sold by existing shareholders: 1
2026-06-05
Shareholder vote results · Q2 2026
BRIGHTSPRING HEALTH SERVICES, INC. - 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held May 21, 2026 with 186,457,085.30 shares present or represent
2026-05-21
Quarterly report · Q1 2026
BRIGHTSPRING HEALTH SERVICES, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues: $3,613.7 million (Q1 2026) vs. $2,878.1 million (Q1 202
2026-05-01

Readable in the app.

Deals & corporate news

AnnouncementDate
Full-year 2026 revenue and adjusted EBITDA guidance increased
BrightSpring reported strong third-quarter 2026 results from continuing operations after divesting its Community Living business. Revenue rose 26.4% year over year to $4.213 billion, while g
2026-10-30
Q2 2026 results announced; full year 2026 revenue and EBITDA guidance increased
BrightSpring Health Services reported strong second quarter 2026 results and raised full-year guidance. Key highlights: Revenue grew 23% to $3.87 billion (vs. $3.15 billion last year), Gross
2026-07-31
Q1 2026 results reported; full year 2026 revenue and EBITDA guidance increased
BrightSpring Health Services reported strong Q1 2026 results and raised full-year guidance. Revenue jumped 25.6% to $3.6 billion, while gross profit surged 42.5% to $482 million and net inco
2026-05-01
Q4 2025 results and full year 2026 revenue and EBITDA guidance initiated
BrightSpring Health Services reported strong 2025 financial results and provided 2026 guidance. Revenue grew 28.2% year-over-year to $12.9 billion, driven by its two business segments: Pharm
2026-02-27

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for BrightSpring Health Services, Inc. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.